Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects

Thyroid

Volumn 17, Issue 3, 2007, Pages 249-258

  Samuels, Mary H ^a   Schuff, Kathryn G ^a   Carlson, Nichole E ^a   Carello, Phyllis ^a   Janowsky, Jeri S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DECLARATIVE MEMORY; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; HYPOTHYROIDISM; MENTAL DISEASE; MOOD; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOLOGIC ASSESSMENT; RATING SCALE; SELF REPORT; SHORT FORM 36; SYMPTOM CHECKLIST 90; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; WORKING MEMORY;

ADULT; AFFECT; CASE-CONTROL STUDIES; COGNITION; FEMALE; HUMANS; HYPOTHYROIDISM; MEMORY; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; THYROID GLAND; THYROID HORMONES; THYROTROPIN; THYROXINE;

EID: 34147189574     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0252     Document Type: Article

References (70)

1. Sinha AK, Pickard MR, Kim KD, Ahmed MT, al Yamata F, Evans IM, Elkins RP 1994 Perturbation of thyroid hormone homeostasis in the adult and brain function. Acta Med Austriaca 21:35-43.
2. Bould E, Woolley CS, CeEwen BS 1991 The hippocampal formation: morphological changes induced by thyroid, gonadal and adrenal hormones. Psychoneuroendocrinology 16:67-84.
3. Madeira MD, Sousa N, Lima-Andrade M, Calheiros F, Cadete-Leite A, Paula-Barbosa MM 1992 Selective vulnerability of the hippocampal pyramidal neurons to hypothyroidism in male and female rats. J Comp Neurol 322:501-508.
4. Tejani-Butt SM, Yang J 1994 A time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography. Neuroendocrinology 59:235-244.
5. Hemmings SJ, Shuaib A 1998 Hypothyroidism-evoked shifts in hippocampal adrenergic receptors: implications to ischemia-induced hippocampal damage. Mol Cell Biochem 185:161-169.
6. Whybrow PC, Prange AJ, Treadway CR 1969 Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch Gen Psychiatry 20:48-63.
7. Denicoff KD, Joffe RT, Lakshmanan MC, Robbins J, Rubinow DR 1990 Neuropsychiatric manifestations of altered thyroid state. Am J Psychiatry 147:94-99.
8. Osterweil D, Syndulko K, Cohen SN, Pettles-Jennings PD, Hesshman JM, Cummings JL, Tourtellotte MN, Solomon DH 1992 Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 40:325-335.
9. Mennemeier M, Garner RD, Heilman KM 1993 Memory, mood and measurement in hypothyroidism. J Clin Exp Neuropsychol 15:822-831.
10. Dugbartey AT 1998 Neurocognitive aspects of hypothyroidism. Arch Intern Med 158:1413-1418.
11. Burmeister LA, Ganguli M, Dodge HH, Toczek T, DeKosky ST, Nebes RD 2001 Hypothyroidism and cognition: preliminary evidence for a specific effect in memory. Thyroid 11:1177-1185.
12. Haggerty JJ, Evans DL, Prange AJ 1986 Organic brain syndrome associated with marginal hypothyroidism. Am J Psychiatry 143:785-786.
13. Peabody CA, Thornton JE, Tinklenberg JR 1986 Progressive dementia associated with thyroid disease. J Clin Psychiatry 47:100.
14. Lindeman RD, Schade DS, LaRue A, Romero LJ, Liang HC, Baumgartnes RN, Koehles KM, Garry PJ 1999 Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 47:703-709.
15. Nystrom E, Hamburger A, Lindstedt G, Lundquist C, Wikkelso C 1997 Cerebrospinal fluid proteins in subclinical and overt hypothyroidism. Acta Neurol Scand 95:311-314.
16. Constant EL, Adam S, Seron X, Bruyer R, Seghers A, Daumerie C 2005 Anxiety and depression, attention, and executive functions in hypothyroidism. J Int Neuropsychol Soc 11:535-544.
17. Botella-Carretero JI, Galan JM, Caballero C, Sancho J, Escobar-Morreale HF 2003 Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 10:601-610.
18. Bono G, Fancellu R, Blandini F, Santoro G, Mauri M 2004 Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 110:59-66.
19. Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M, Chisin R, Bonne D 2004 Regional cerebral blood flow in patients with mild hypothyroidism. J Nucl Med 45:1712-1715.
20. Manciet G, Dartigues F, Decamps A, Barberger-Gateau P, Letenneur L, Latapie MJ, Latapie JL 1995 The PAUID survey and correlates of subclinical hypothyroidism in elderly community residents in the south-west of France. Age Aging 24:235-241.
21. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G 1988 A double-blind cross-over 12-month study of L-thyroxine treatment of women with "subclinical" hypothyroidism. Clin Endocrinol (Oxf) 29:63-76.
22. Monzani F, DelGuerra P, Caraccio N, Pruneti CA, Pucci E, Luisi M, Baschieri L 1993 Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 71:367-371.
23. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L, Carbolte R 1996 Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 11:744-749.
24. Baldini IM, Vita A, Mauri MC, Amodei V, Carrisi M, Bravn S, Cantalamessa L 1997 Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 21:925-935.
25. Luboschitzky R, Oberman AS, Kaufman N, Reichman N, Flatau E 1996 Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci 32:60-65.
26. Jorde R, Waterloo K, Storhaug H, Nymes A, Sundsfjord J, Jenssen TG 2006 Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 91:145-153.
27. Jenovsky J, Ruzicka E, Spackova N, Hejdukova B 2002 Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment. Endocr Regul 36:115-122.
28. Saravanan R, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on "adequate" doses of L-thyroxine: results of a large controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57:577-585.
29. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J 2005 Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing 1-thyroxine plus liothyronine with 1-thyroxine alone. Ann Intern Med 142:412-424.
30. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, Wiersinga WM 2005 Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153:747-753.
31. Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, Gillett MJ, Gilbert R, Tanner M, Stuckey BG 2006 Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being or quality of life: results of a double blind, randomized clinical trial. J Clin Endocrinol Metab 91:2624-2630.
32. Budson AE, Price BH 2005 Memory dysfunction. N Engl J Med 325:692-699.
33. Razvi S, McMiilan CV, Weaver JU 2005 Instruments used in measuring symptoms, health status, and quality of life in hypothyroidism: a systematic qualitative review. Clin Endocrinol (Oxf) 63:617-624.
34. Spreen O, Strauss EA 1998 Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York, pp 90-102.
35. Spreen O, Strauss EA 1998 Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York, pp 612-616.
36. Wetzler S, Marlowe DB 1993 The diagnosis and assessment of depression, mania, and psychosis by self-report. J Pers Assess 60:1-31.
37. Spreen O, Strauss EA 1998 Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York, pp 644-646.
38. Lezak MD 1995 Neuropsychological Assessment. Oxford University Press, New York, pp 456-461.
39. Spreen O, Strauss EA 1998 Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York, pp 341-363.
40. Cohen JD, Forman S, Braver TS, Casey BJ, Servan-Schreiber D, Noll DC 1993 Activation of prefrontal cortex in a nonspatial working memory task with functional MRI. Hum Brain Map 1:293-304.
41. Spreen O, Strauss EA 1998 Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Oxford University Press, New York, pp 208-212.
42. Van Gorp WG, Altshuler L, Theberge DC, Mintz J 1999 Declarative and procedural memory in bipolar disorder. Biol Psychiatry 46:525-531.
43. Brown H, Prescott R 1999 Applied Mixed Models in Medicine. John Wiley and Sons, Indianapolis, p 33-83.
44. Shults J, Whitt MC, Kumanyika S 2004 Analysis of data with multiple sources of correlation in the framework of generalized estimating equations. Stat Med 23:3209-3226.
45. Santisteban P, Bernal J 2005 Thyroid development and effect on the nervous system. Rev Endocr Metab Disord 6:217-228.
46. Rao SN, Katiyar BC, Nair KR, Misra S 1980 Neuromuscular status in hypothyroidism. Acta Neurol Scand 61:167-177.
47. Ozata M, Ozkardes A, Corakci A, Gundogan MA 1995 Subclinical hypothyroidism does not lead to alterations either in peripheral nerves or in brainstem auditory evoked potentials (BAEPs). Thyroid 5:201-205.
48. Misiunas A, Niepomniszcze H, Ravera B, Faraj G, Faure E 1995 Peripheral neuropathy in subclinical hypothyroidism. Thyroid 5:283-286.
49. Bell GM, Todd WT, Forfar JC, Martyn C, Wathen CG, Gow S, Riemersma R, Toft AD 1985 End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol (Oxf) 22:83-89.
50. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR for the Clinical Significance Consensus Meeting Group 2002 Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371-383.
51. Ware JE, Kosinski M 2001 SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1, 2nd edition. QualityMetric Incorporated, Lincoln, Rhode Island, pp 60-61.
52. Blissmer B, Riebe D, Dye G, Ruggiero L, Greene G, Caldwell M 2006 Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24-month follow-up effects. Health Qual Life Outcomes 4:43-48.
53. Kivitz A, Ma C, Ahdieh H, Galer BS 2006 A 2-week, multicenter, randomized, double-blind, placebo-controlled dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo I adults with pain associated with osteoarthritis of the hip or knee. Clin Ther 28:352-364.
54. Singh SN, Tang XC, Singh BN, Durian P, Reda DJ, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewr HD Jr, Lopez B, Raisch DW, Ezekowitz MD, SAFE-T Investigators 2006 Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 48:731-733.
55. Harrison EL, Fillmore MT 2005 Social drinkers underestimate the additive impairing effects of alcohol and visual degradation on behavior functioning. Psychopharmacology (Berl) 177:459-464.
56. Hollowell JG, Steahling NW, Flanders WD, Hannan WH, Gunter EW, Spencer CA, Bravesman LE 2002 Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
57. Surks MI, Schadlow AR, Oppenheimer JH 1972 A new radioimmunoassay for plasma l-triioothryonine: measurements in thyroid disease and in patients maintained on hormonal replacement. J Clin Invest 51:3104-3113.
58. Saberi M, Utiger RD 1974 Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab 39:923-927.
59. Jennings PE, O'Malley BP, Griffin KE, Northover B, Rosenthal FD 1984 Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for tissue thyrotoxicosis. Br Med J 289:1645-1647.
60. Fish LH, Schwartz HL, Cavanaugh J, Steifes MW, Bantle JF, Oppenheimer JH 1987 Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. N Engl J Med 316:764-770.
61. Lievendahl K, Helenius T, Lamberg BA, Mahonen H, Wagar G 1987 Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinol 116: 418-424.
62. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP 2004 Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 14:271-275.
63. Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P 1996 Bone mass, bone turnover, and body composition in former hypothyroid patients receiving replacement therapy. Eur J Endocrinol 134:702-709.
64. Miyakawa M, Tsushima T, Murakami H, Isozaki O, Takano K 1999 Serum leptin levels and bioelectrical impedance assessment of body composition in patients with Graves' disease and hypothyroidism. Endocr J 46:665-673.
65. al-Adsani H, Hoffer LJ, Silva JE 1997 Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 82:1118-1125.
66. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Oresen L, Jorgenser T 2005 Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019-4024.
67. Pop VJ, Maartens LH, Leusink G, van San MJ, Knottnesus AA, Word AM, Metcalfe R, Weetmon AP 1998 Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 83:3194-3197.
68. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, Carpinello B, Dell'Osso L, Mariotti S 2004 The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 4:25-29.
69. Carta MG, Hardoy MC, Carpiniello B, Murru A, Marci AR, Carbune F, Deiana L, Cadeddu M, Mariotti S 2005 A case control study on psychiatric disorders in Hashimoto disease and euthyroid goiter: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin Pract Epidemol Ment Health 1:23-27.
70. Engum A, Bjoro T, Mykletun A, Dahl AA 2005 Thyroid autoimmunity, depression, and anxiety: are there any connections? An epidemiological study of a large population. J Psychosom Res 59:263-268.